
The aim of treatment in rheumatoid arthritis is to achieve drug-free remission by gradually reducing and stopping the use of biologic DMARDs. Nevertheless, recent real-world evidence indicates that discontinuing DMARDs happens less often than what clinical trials have shown. This raises the significance of questioning what the ultimate treatment goal should be.
Like
Save
Share